2124 POSTER Triple combination of oral vinorelbine, capecitabine and trastuzumab as first-line treatment in HER2-positive metastatic breast cancer (MBC): latest results of an international phase II trial.

Details

Language :

English

ISSN :

13596349

Volume :

5

Issue :

4

Database :

Supplemental Index

Journal :

EJC Supplements

Publication Type :

Academic Journal

Accession number :

27456985

Full Text :

https://doi.org/10.1016/S1359-6349(07)70886-8